Your browser doesn't support javascript.
loading
Epidemiology of Takayasu arteritis in Shanghai: A hospital-based study and systematic review.
Sun, Ying; Yin, Meng-Meng; Ma, Li-Li; Dai, Xiao-Min; Lv, Liang-Jing; Chen, Xiao-Xiang; Ye, Shuang; Li, Ting; Chen, Jie; Zhao, Dong-Bao; Kong, Rui-Na; Wei, Qiang-Hua; Yang, Guang-Hui; Gong, Su-Gang; Yang, Cheng-de; Liu, Hong-Lei; Xue, Yu; Tang, Jian-Ping; Feng, Run; Peng, Ai; Qin, Ling; Liu, Hua; Su, Xiao; Huang, Hui-Ping; Guan, Jian-Long; Luo, Dan; Dai, Sheng-Ming; Zhao, Fu-Tao; Zhu, Zhen-Hang; Zhang, Xiao-Yan; Han, Jie; Wang, Jia-Yi; Xiao, Chun-Yuan; Xu, Hu-Ji; Wu, Xin; He, Dong-Yi; Mao, Jian-Chun; Zhu, Zhu-Jing; Xue, Luan; Li, Ben; Lin, Jiang; Zou, Jian-Zhou; Sun, Xiao-Ning; Ding, Jing; Dong, Zhi-Hui; Wang, Xiang-Fei; Jiang, Lin-di.
Afiliación
  • Sun Y; Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Yin MM; Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Ma LL; Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Dai XM; Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Lv LJ; Department of Rheumatology, Renji Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.
  • Chen XX; Department of Rheumatology, Renji Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.
  • Ye S; Department of Rheumatology, Renji Hospital South Campus, Shanghai JiaoTong University School of Medicine, Shanghai, China.
  • Li T; Department of Rheumatology, Renji Hospital South Campus, Shanghai JiaoTong University School of Medicine, Shanghai, China.
  • Chen J; Department of Rheumatology, Renji Hospital South Campus, Shanghai JiaoTong University School of Medicine, Shanghai, China.
  • Zhao DB; Department of Rheumatology and Immunology, Changhai Hospital, Second Military Medicine University, Shanghai, China.
  • Kong RN; Department of Rheumatology and Immunology, Changhai Hospital, Second Military Medicine University, Shanghai, China.
  • Wei QH; Department of Rheumatology, Shanghai General Hospital, Shanghai, China.
  • Yang GH; Department of Rheumatology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Gong SG; Department of Cardio-Pulmonary Circulation, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Yang CD; Department of Rheumatology and Immunology, Shanghai JiaoTong University School of Medicine Affiliated Ruijin Hospital, Shanghai, China.
  • Liu HL; Department of Rheumatology and Immunology, Shanghai JiaoTong University School of Medicine Affiliated Ruijin Hospital, Shanghai, China.
  • Xue Y; Department of Rheumatology, Huashan Hospital, Fudan University, Shanghai, China.
  • Tang JP; Division of Rheumatology and Immunology, Tongji Hospital of Tongji University School of Medicine, Shanghai, China.
  • Feng R; Division of Rheumatology and Immunology, Tongji Hospital of Tongji University School of Medicine, Shanghai, China.
  • Peng A; Department of Nephrology & Rheumatology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Qin L; Department of Nephrology & Rheumatology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Liu H; Department of Cardiology, Shanghai Chest Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.
  • Su X; Department of Rheumatology, Shanghai municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Huang HP; Department of Rheumatology, Shanghai municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Guan JL; Department of Rheumatology, Huadong Hospital, Fudan University, Shanghai, China.
  • Luo D; Department of Rheumatology, Huadong Hospital, Fudan University, Shanghai, China.
  • Dai SM; Department of Rheumatology & Immunology, Shanghai JiaoTong University Affiliated Sixth People's Hospital, Shanghai, China.
  • Zhao FT; Department of Rheumatology and Immunology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, China.
  • Zhu ZH; Department of Rheumatology and Immunology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, China.
  • Zhang XY; Department of Renal and Rheumatology, Xinhua Hospital Affiliated To Shanghai JiaoTong University School of Medicine, Shanghai, China.
  • Han J; Department of Rheumatology, Shanghai East Hospital, Tongji University, Shanghai, China.
  • Wang JY; Department of Rheumatology, Shanghai East Hospital, Tongji University, Shanghai, China.
  • Xiao CY; Department of Rheumatology, Shanghai East Hospital, Tongji University, Shanghai, China.
  • Xu HJ; Department of Rheumatology and Immunology, Changzheng Hospital, Secondary Military Medicine University, Shanghai, China.
  • Wu X; Department of Rheumatology and Immunology, Changzheng Hospital, Secondary Military Medicine University, Shanghai, China.
  • He DY; Department of Rheumatology, Shanghai Guanghua Hospital of Integrated Traditional and Western Medicine, Shanghai, China.
  • Mao JC; Department of Rheumatology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Zhu ZJ; Department of Rheumatology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Xue L; Department of Rheumatology and Immunology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Li B; Department of Rheumatology and Immunology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Lin J; Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zou JZ; Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Sun XN; Department of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Ding J; Department of Neurology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Dong ZH; Department of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Wang XF; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Jun-Ying; Fudan University Library, Shanghai, China.
  • Jiang LD; Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.
Int J Rheum Dis ; 24(10): 1247-1256, 2021 Oct.
Article en En | MEDLINE | ID: mdl-34314100
BACKGROUND: Takayasu arteritis (TAK) is a rare large vessel vasculitis, and epidemiological data on TAK are lacking in China. Thus, we designed this study to estimate the TAK prevalence and incidence in residential Shanghai, China. METHODS: Data on diagnosed TAK cases aged over 16 years were retrieved from 22 tertiary hospitals in Shanghai through hospital electronic medical record systems between January 1, 2015 and December 31, 2017 to estimate the prevalence and incidence. A systematic literature review based on searches in PubMed, Ovid-Medline, Excerpta Medica Database (EMBASE), Web of Science, and China National Knowledge Infrastructure (CNKI) was performed to summarize TAK distribution across the world. RESULTS: In total 102 TAK patients, with 64% female, were identified. The point prevalence (2015-2017) was 7.01 (95% CI 5.65-8.37) cases per million, and the mean annual incidence was 2.33 (1.97-3.21) cases per million. The average age of TAK patients was 44 ± 16 years, with the highest prevalence (11.59 [9.23-19.50] cases per million) and incidence (3.55 [0.72 3.74] cases per million) in the 16 to 34 years population. Seventeen reports were included in the system review, showing that the epidemiology of TAK varied greatly across the world. The incidence and prevalence were both relatively higher in Asian countries, with the prevalence ranging 3.3-40 cases per million and annual incidence ranging 0.34-2.4 cases per million. CONCLUSIONS: The prevalence and incidence of TAK in Shanghai was at moderate to high levels among the previous reports. The disease burden varied globally among racial populations.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Arteritis de Takayasu Tipo de estudio: Clinical_trials / Incidence_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies / Systematic_reviews Límite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Int J Rheum Dis Asunto de la revista: REUMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Arteritis de Takayasu Tipo de estudio: Clinical_trials / Incidence_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies / Systematic_reviews Límite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Int J Rheum Dis Asunto de la revista: REUMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: China